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Covid-19-related pancreatic injury
Editor
We read with great interest the Lead-
ing Article by Spinelli and Pellino1,
highlighting their experience of the
COVID-19 pandemic currently grip-
ping the world. We were particularly
drawn to their description of COVID-19
patients presenting with gastrointestinal
symptoms mimicking surgical diseases,
specifically a ‘pancreatitis-like clinical
presentation’. Our initial observations
as UK surgeons amidst this outbreak are
similar.
We observe that this contrasts with
the largest published Chinese case series
demonstrating that gastrointestinal
symptoms are uncommon (approx-
imately 5 per cent), with only mild
biochemical liver function derange-
ments (10 to 20 per cent)2 and our
existing knowledge that viral infec-
tion is an uncommon cause of acute
pancreatitis, usually resulting only in
mild inflammation3. Furthermore,
there are no published reports to date
of coronavirus-induced pancreatitis,
including other Coronaviridae like those
causing SARS and MERS.
We argue, however, the potential for
pancreatic injury remains. Pancreatic
cells highly express angiotensin-
converting enzyme 2 (ACE2)4, the
transmembrane protein required for
SARS-CoV-2 entry. Patient cohorts
with approximately 40 per cent of
COVID-19 patients presenting with
gastrointestinal symptoms, including
abdominal pain, exist5. Additionally,
up to 16 per cent of patients with
severe SARS-CoV-2 infection have
raised serum amylase and lipase, with
7 per cent displaying accompany-
ing significant pancreatic changes on
CT4. Crucially, the rate of increase
of COVID-19 is phenomenal, with
now over 2 500 000 documented cases
globally (8177 for SARS and 2494 for
MERS)6, meaning atypical COVID-19
presentations and surgical pathology
with concomitant COVID-19 are more
likely, such as acute pancreatitis, which
may have poorer outcomes secondary to
a double pulmonary insult. Considering
this, we hypothesize that COVID-19-
associated pancreatic dysfunction may
exist.
An assessment of COVID-19 status
should take primacy when assessing
the acute surgical patient, with due
consideration of lymphocyte count and
chest X-ray. A crucial deficiency in
abdominal pain reporting and serum
amylase measurement exists in the inter-
national literature, requiring urgent
rectification. Only with global collab-
orative research networks that grow
as rapidly as the pandemic, will we be
able to evaluate the significance of this
clinical phenomenon and how best to
treat it.
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